New technology from Smith & Nephew offers more efficient uterine fibroid removal
Smith & Nephew (LSE:SN NYSE:SNN), the global medical technology business, today introduced the newest addition to its innovative TRUCLEAR™ System, the TRUCLEAR ULTRA Reciprocating Morcellator 4.0
Press Release – December 18, 2012
read more...

Favorable verdict in gynecology patent infringement suit
Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announces that earlier this week,, a jury in the US District Court for Massachusetts (Boston) found that Hologic, Inc. (Bedford, Mass.) infringed two US Patents held by Smith & Nephew
read more...

TRUCLEAR 5.0 System offers US surgeons a patient-friendly option for removing intrauterine polyps in office or clinical setting
Press Release - June 6, 2012
read more...